熱門資訊> 正文

Hims Hers Health 2026年第一季度盈利预览

2026-05-09 05:35

Hims & Hers Health(HIMS) 0
諾和諾德(NVO) 0

Hims & Hers Health (HIMS) is scheduled to announce Q1 earnings results on Monday, May 11th, after market close.
The consensus EPS Estimate is $0.13 and the consensus Revenue Estimate is $616.85M (+5.3% Y/Y).
Over the last 1 year, HIMS has beaten EPS estimates 0% of the time and has beaten revenue estimates 100% of the time.
Over the last 3 months, EPS estimates have seen 0 upward revisions and 3 downward. Revenue estimates have seen 0 upward revisions and 9 downward.
Recent earnings Analysis from our contributors:Hims Earnings: Stability Could Trigger A Squeeze

More on Hims & Hers Health

Hims Earnings: Stability Could Trigger A Squeeze
Hims & Hers, Novo Nordisk: FDA GLP-1 Compounding Ruling May Actually Favor Hims
FDA Peptide Review, A Big Moment For Hims & Hers (Rating Upgrade)
Most and least shorted mid-to mega-cap healthcare stocks in May
Hims rises as J.P. Morgan initiates at Overweight on rich catalyst path

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。